Finnrick - Ensuring a Safer and More Transparent Supply Chain
Yimei

Yimei

Tirzepatide

Finnrick tested 6 samples of Tirzepatide (GLP-1 and GIP agonist) from Yimei between 9 Jan 2026 and 28 Apr 2026. Test scores average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).

Finnrick Rating™
Yimei
Tirzepatide
Tested 6 Samples
Last test 28 Apr 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Tirzepatide tests from top-rated vendors:

All Tirzepatide tests from Yimei

Samples are tested in commercial labs

Tests Count

6

Scores

AVG6.9MIN4.7MAX9.3

Last

28 Apr 2026

First

9 Jan 2026
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityEndotoxinsBatch IDContainerTested AtSent By
28 Apr 2026View7.030mg36.5mg+21.7%99.90%n/a800-30No Label / Silver Crimp / Green CapLab EPublic
2 Mar 2026View4.810mg13.8mg+38.0%99.90%
below LOQ
(no batch ID)White Label / Silver Crimp / Gray CapLab EPublic
26 Feb 2026View9.320mg21mg+5.0%99.63%n/a(800-20)(no data)Lab EPublic
20 Feb 2026View7.85mg4.72mg-5.6%99.90%n/a(no batch ID)No Label / Silver Crimp / Yellow CapLab EPublic
15 Jan 2026View4.720mg24.1mg+20.5%99.80%n/a(no batch ID)No Label / Silver Crimp / Violet CapLab GPublic
9 Jan 2026View7.920mg20.4mg+2.0%99.87%n/a(no batch ID)No Label / Silver Crimp / Red CapLab EPublic